CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for R&G PharmaStudies Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

R&G PharmaStudies Co Ltd
Phone: +86 1088019152p:+86 1088019152 BEIJING, BEJ  100048  China Ticker: 301333301333
Business Summary
R&G PharmaStudies Co Ltd is a China-based company mainly engaged in the provision of professional clinical trial outsourcing services. The Company's main businesses include clinical trial operation services (CO Services), clinical trial site management services (SMO Services), biological sample testing services (BA Services), data management and statistical analysis services (DM/ST Services), clinical trials Consulting Services, Clinical Pharmacology Services (CP Services) and others. The Company operates its businesses primarily in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202412/31/2023Yes----

Industries
SIC Code Description
8071 Medical laboratories
8734 Testing laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager JieWu 62 7/1/2015 7/1/2015
Chief Financial Officer QianZhao 39 1/1/2018 1/1/2018
Chief Scientific Officer, Deputy General Manager GangChen 67 7/1/2016 7/1/2016
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 2,042 (As of 12/31/2023)
Outstanding Shares: 96,000,000 (As of 3/31/2024)
Shareholders: 5,642
Stock Exchange: SHE
Fax Number: +86 1088019978


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024